Back to search
Basal Ganglia Intracerebral Hemorrhage
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Basal Ganglia Intracerebral Hemorrhage trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Basal Ganglia Intracerebral Hemorrhage trials you may qualify forThe main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.
Intracerebral hemorrhage (ICH) is one of the most devastating forms of stroke, with high rates of death and disability worldwide. Despite advances in medical an…
A nationwide, prospective, multicenter randomized controlled clinical trial to evaluate the therapeutic effects of the fiber tract-based artificial intelligence…
The goal of this observational study is to evaluate whether transcranial Doppler ultrasound, combined with artificial intelligence (AI), can help identify intra…
This observational cohort study evaluates the safety and effectiveness of minimally invasive surgery (MIS) compared with standard medical management in adults w…
This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3…
This is an exploratory single-center prospective study of 20 subjects with primary basal ganglia ICH who will receive early MIPS in combination with perioperati…
MINUTE is a prospective, multi-center, randomized, controlled, blinded assessor, adaptive enrichment design, clinical trial. Eligible patients with spontaneous…
Spontaneous cerebral hemorrhage is one of the main causes of death and disability all over the world, accounting for 20%-30% of all cerebrovascular diseases. Mi…